Published in Diabetes on January 09, 2015
The missing link: studying the alternative TGF-β pathway provides a unifying theory for different components of diabetic nephropathy. Diabetes (2015) 0.77
Transforming growth factor β1 and diabetic nephropathy. Am J Physiol Renal Physiol (2015) 0.75
Reduction in podocyte SIRT1 accelerates kidney injury in aging mice. Am J Physiol Renal Physiol (2017) 0.75
Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy. Drug Des Devel Ther (2017) 0.75
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87
TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med (2007) 9.77
A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol (2002) 4.63
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A (2000) 4.08
Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science (2011) 3.49
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A (2000) 3.48
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol (2006) 3.19
Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature (1999) 3.16
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell (2008) 3.04
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia (2004) 2.60
Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol (2010) 2.52
Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens (2008) 2.45
Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol (2004) 2.44
Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes (1996) 2.42
Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int (2002) 2.34
Transcriptome analysis of human diabetic kidney disease. Diabetes (2011) 2.32
A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol (2004) 2.17
Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol (2000) 2.16
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev (2008) 2.14
Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes (2003) 1.92
Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res (2003) 1.87
Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries. Kidney Int (2006) 1.81
Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell (2012) 1.79
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia (2008) 1.70
Using a histone yellow fluorescent protein fusion for tagging and tracking endothelial cells in ES cells and mice. Genesis (2005) 1.69
Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol (1995) 1.60
ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res (2011) 1.55
Abnormal angiogenesis in diabetic nephropathy. Diabetes (2009) 1.53
Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta (2013) 1.51
Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes (2010) 1.48
Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol (1999) 1.48
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol (2009) 1.48
ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest (2010) 1.45
Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes (2012) 1.39
Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol (2007) 1.38
Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem (2009) 1.29
MAPKs (ERK1/2, p38) and AKT can be phosphorylated by shear stress independently of platelet endothelial cell adhesion molecule-1 (CD31) in vascular endothelial cells. J Biol Chem (2005) 1.25
Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One (2011) 1.24
Transforming growth factor-beta signaling and tumor angiogenesis. Front Biosci (Landmark Ed) (2009) 1.15
Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol (1997) 1.13
The TGF-beta pseudoreceptor gene Bambi is dispensable for mouse embryonic development and postnatal survival. Genesis (2007) 1.13
Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes (1997) 1.11
Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice. Biochem Biophys Res Commun (2003) 1.08
Expression of HIV transgene aggravates kidney injury in diabetic mice. Kidney Int (2013) 1.00
Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol (2013) 0.98
Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis (2001) 0.97
The endothelium in diabetic nephropathy. Semin Nephrol (2012) 0.93
New targets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens (2013) 0.92
Early phases in the development of diabetic glomerulopathy. Acta Med Scand Suppl (1974) 0.91
Erk in kidney diseases. J Signal Transduct (2011) 0.89
Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy. AIDS (2013) 0.88
BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling. PLoS One (2012) 0.85
Vessel wall BAMBI contributes to hemostasis and thrombus stability. Blood (2014) 0.83
Choosing the right mouse model for diabetic nephropathy. Kidney Int (2010) 0.83
Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice. PLoS One (2013) 0.83
Activation of mitogen-activated protein kinase cascade in diabetic glomeruli and mesangial cells cultured under high glucose conditions. Kidney Int Suppl (1997) 0.78
Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro. Am J Physiol Renal Physiol (2014) 0.86
Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression. PLoS One (2014) 0.79
Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. J Diabetes Res (2017) 0.78
The Role of Endoplasmic Reticulum Stress in Diabetic Nephropathy. Curr Diab Rep (2017) 0.75
Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy. Kidney Dis (Basel) (2021) 0.75
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury. J Cell Mol Med (2017) 0.75
Efficacy and safety of intravenous paricalcitol treatment in Chinese hemodialysis patients: a real-world database analysis. Ann Palliat Med (2022) 0.75